ASRS 2023: Retinal Vascular Disease

Highlights From ASRS - Retinal Vascular Disease

Oct 23, 2023

...

Aflibercept 8 mg Provides Vision Gains With Fewer Injections in DME

Aug 22, 2023
Racial & Ethnic Diversity Lacking in Diabetic Retinopathy Trials

Aug 21, 2023
Aflibercept 8 mg Provides “Greater Therapeutic Benefit” in Neovascular AMD

Aug 08, 2023
Using OCTA Blood Flow Analysis to Detect Early Diabetic Retinopathy

Aug 07, 2023

Advertisement